Author(s):
Devidutta R.R. Rout, Subhasis Mishra, Atanu Kumar Bal, Bibendu Bal, Bikas R. Mohanty, Sashibhusan Dash
Email(s):
dratanubal1974@yahoo.co.in
DOI:
10.52711/0974-360X.2026.00090 
Address:
Devidutta R.R. Rout1, Subhasis Mishra2, Atanu Kumar Bal3*, Bibendu Bal4, Bikas R. Mohanty5, Sashibhusan Dash6
1,3,4Department of Pathology, Pandit Raghunath Murmu Medical College and Hospital, Baripada, 757107, Odisha, India.
2Department of Pathology, JK Medical College and Hospital, Jajpur, 755001, Odisha, India.
5Department of Pharmacology, Pandit Raghunath Murmu Medical College and Hospital, Baripada, 757107, Odisha, India.
6Multi-Disciplinary Research Unit, Pandit Raghunath Murmu Medical College and Hospital, Baripada, 757107, Odisha, India.
*Corresponding Author
Published In:
Volume - 19,
Issue - 2,
Year - 2026
ABSTRACT:
Lymphadenopathy diagnosis requires accurate tools like FNAC. The Sydney System was introduced to standardize reporting, but diagnostic variability persists, necessitating localized validation. This study aimed to evaluate the Sydney System's diagnostic accuracy, sensitivity, specificity, PPV, and NPV for lymph node lesions. A two-year cross-sectional study (Nov 2022-Oct 2024) at PRM Medical College and Hospital analyzed 448 non-guided lymph node FNAs. Cases with histopathological or comprehensive clinical/radiological follow-up were included. Two cytopathologists independently categorized smears using the five-tiered Sydney System (L1-L5), integrating ancillary study results. Statistical analysis determined diagnostic metrics and Risk of Malignancy (ROM).The 21-30 age group had the most cases (31.25%). Cervical (33.92%) and unusually high supraclavicular (23.21%) lesions were common, the latter strongly correlating with malignancy. Sydney System categorization showed balanced benign (43.75%) and malignant (41.9%) diagnoses. Granulomatous lymphadenitis was frequent benign; metastatic squamous cell carcinoma and Non-Hodgkin Lymphoma (NHL) were common malignancies. ROM for Category III (Atypical) was 66.67%, with all malignant cases confirmed as NHL. Category IV (Suspicious) showed an 80% ROM. Notably, non-diagnostic Category I had a 33.33% ROM. Overall diagnostic performance was high: sensitivity 91.49%, specificity 93.10%, PPV 95.56%, NPV 87.10%, and accuracy 92.11%,. This study provides compelling evidence for the Sydney System's robust diagnostic accuracy and utility in risk-stratifying lymph node lesions. Key insights include the high ROMs for indeterminate categories (especially NHL in Category III) and the significant risk associated with non-diagnostic samples, guiding clinical management. The research confirms the Sydney System's value as a standardized tool for clinical practice.
Cite this article:
Devidutta R.R. Rout, Subhasis Mishra, Atanu Kumar Bal, Bibendu Bal, Bikas R. Mohanty, Sashibhusan Dash. Diagnostic Utility and Risk Stratification of the Sydney System for Lymph Node Fine-Needle Aspiration Cytology: A Hospital-Based Study. Research Journal of Pharmacy and Technology. 2026;19(2):617-4. doi: 10.52711/0974-360X.2026.00090
Cite(Electronic):
Devidutta R.R. Rout, Subhasis Mishra, Atanu Kumar Bal, Bibendu Bal, Bikas R. Mohanty, Sashibhusan Dash. Diagnostic Utility and Risk Stratification of the Sydney System for Lymph Node Fine-Needle Aspiration Cytology: A Hospital-Based Study. Research Journal of Pharmacy and Technology. 2026;19(2):617-4. doi: 10.52711/0974-360X.2026.00090 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-2-19
REFERENCES:
1. Alqaidy D, Althomali H, Almaghrabi A. Sydney Reporting System for Lymph Node Fine-Needle Aspiration and Malignancy Risk Stratification: Is It of Clinical Value? Diagnostics (Basel). 2024 Aug 17; 14(16): 1801. doi: 10.3390/diagnostics14161801.
2. Al Qout MM, Al Hamoud M, Al Qahtani MS, Alqahtani AY, Asiri AH, Alshahrani AA. The Diagnostic Value of Fine-Needle Aspiration Cytology in Cervical Lymphadenopathy in Correlation to Postoperative Histopathological Results in a Tertiary Care Center in Saudi Arabia. Cureus. 2023 Sep 29; 15(9): e46210. doi: 10.7759/cureus.46210.
3. Caputo A, Fraggetta F, Cretella P, Cozzolino I, Eccher A, Girolami I, et al. Digital Examination of LYmph node CYtopathology Using the Sydney system (DELYCYUS):An international, multi-institutional study. Cancer Cytopathol. 2023 Nov; 131(11): 679-692. doi: 10.1002/cncy.22741.
4. Al-Abbadi MA, Barroca H, Bode-Lesniewska B, Calaminici M, Caraway NP, Chhieng DF, et al. A Proposal for the Performance, Classification, and Reporting of Lymph Node Fine-Needle Aspiration Cytopathology: The Sydney System. Acta Cytol. 2020; 64(4): 306-322. doi: 10.1159/000506497.
5. Liang S, Cozzolino I, Zeppa P, Field AS. The Sydney system for lymph node FNA biopsy cytopathology: A detailed analysis of recent publications and meta-analysis and a proposal for the components of an ideal prospective study of a cytopathology reporting system. Cancer Cytopathol. 2024 Dec; 132(12): 745-756. doi: 10.1002/cncy.22890.
6. Qadri SK, Hamdani NH, Shah P, Lone MI, Baba KM. Profile of lymphadenopathy in Kashmir valley: a cytological study. Asian Pac J Cancer Prev. 2012; 13(8): 3621-5. doi: 10.7314/apjcp.2012.13.8.3621.
7. Ton Eryilmaz O, Ucak R, Ozagari AA, Kabukcuoglu F. Diagnostic value of lymph node fine-needle aspiration cytology. Cytojournal. 2021 Apr 12; 18:8. doi: 10.25259/Cytojournal_1_2020.
8. Gupta P, Gupta N, Kumar P, Bhardwaj S, Srinivasan R, Dey P, et al.Assessment of risk of malignancy by application of the proposed Sydney system for classification and reporting lymph node cytopathology. Cancer Cytopathol. 2021 Sep; 129(9): 701-718.
9. Rivas HE, Zarra KV, Pabón LA, Gutierréz MD, Ortiz NZ, Fernández MD, et al. Ultrasound-Guided Fine-Needle aspiration of superficial lymphadenopathy performed by interventional pathologists: the applicability of the Sydney system from 2 years of experience and 363cases. Acta Cytologica.:1-0.
10. Zhou J, Li F, Meng L, Hao F, Liu X, Zhao C, Zhang K, Dong A. Fine needle aspiration cytology for lymph nodes: a three-year study. Br J Biomed Sci. 2016; 73(1): 28-31. doi: 10.1080/09674845.2016.1144947.
11. Malhotra AS, Lahori M, Nigam A, Khajuria A. Profile of Lymphadenopathy: An Institutional Based Cytomorphological Study. Int J Appl Basic Med Res. 2017; 7(2): 100-103. doi:10.4103/2229-516X.205812.
12. Vigliar E, Acanfora G, Iaccarino A, Mascolo M, Russo D, Scalia G, et al. A Novel Approach to Classification and Reporting of Lymph Node Fine-Needle Cytology: Application of the Proposed Sydney System. Diagnostics. 2021; 11(8): 1314.
13. Freeman AM, Matto P. Lymphadenopathy. [Updated 2023 Feb 20]. In: Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513250/
14. Das S, Das A, Das B. Application of the Sydney System for Classification and Reporting Lymph Node Cytopathology to Assess the Risk of Malignancy and its Diagnostic Accuracy. J Cytol. 2024; 41(4): 201-206. doi:10.4103/joc.joc_168_23
15. Pagaro PM, Banerjee B, Khandelwal A,Pandey A, Gambhir A. Spectrum of lymph node lesions as determined by histopathology. Med J DY Patil Univ 2017; 10: 343-8.
16. Ghosh S, Guha P, Verma S, et al. Evaluation of Fine-Needle Aspiration of Lymph Nodes and Assessment of Risk of Malignancy Based on the Sydney System of Reporting Lymph Node Cytology. J Cytol. 2024; 42(1): 11-19. doi:10.4103/joc.joc_20_24
17. Uzun E, Erkilic S. Diagnostic accuracy of Thinprep® in cervical lymph node aspiration: Assessment according to the Sydney system. Diagn Cytopathol. 2022 May; 50(5): 253-262. doi: 10.1002/dc.24943..
18. Juanita J, Ikram D, Sungowati NK, Purnama IP, Amalia A, Ningrati AF, et al. Diagnostic Accuracy of Lymph Nodes Fine Needle Aspiration Biopsy Based on The Sydney System for Reporting Lymph Node Cytology. Asian Pac J Cancer Prev. 2023 Jun 1; 24(6): 1917-1922. doi: 10.31557/APJCP.2023.24.6.1917
19. Makarenko VV, DeLelys ME, Hasserjian RP, Ly A. Lymph node FNA cytology: Diagnostic performance and clinical implications of proposed diagnostic categories. Cancer Cytopathol. 2022 Feb; 130(2): 144-153. doi: 10.1002/cncy.22523.